Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo- controlled, phase 3 trial

Año publicación: 2025

Subir documento: https://drive.google.com/file/d/1IE8f7nr290ZL0iqrFzO5UUZaaaYjaqTF/view?usp=sharing

Nombre investigadores: Linong Ji, Leili Gao, Haibo Xue, Junhang Tian, Kun Wang, Hongwei Jiang, Chongbing Huang, Qiufang Lian, Mingxia Yuan, Ge Gao, Yibing Lu, Jie Han, Wenyan Fu, Haifang Wang, Yawei Zhang, Xiaoguang Shi, Binhong Wen, Bimin Shi, Wen Hu, Tonglan Guo, Ying Xing, Ya Li, Qingju Li, Qing Zheng, Ming Yang, Jing Ning, Mengying Guo, Yao Li, Hai Pan